vs
ARVINAS, INC.（ARVN）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
ARVINAS, INC.的季度营收约是RBB Bancorp的1.3倍（$41.9M vs $32.3M），RBB Bancorp净利率更高（31.5% vs -83.8%，领先115.3%），RBB Bancorp同比增速更快（12.6% vs -59.1%），RBB Bancorp自由现金流更多（$42.6M vs $-59.2M），过去两年ARVINAS, INC.的营收复合增速更高（10.0% vs 7.0%）
Arvinas是一家临床阶段生物技术企业，专注开发PROTAC靶向蛋白降解类疗法，用于治疗癌症及罕见病，核心管线覆盖多个存在未满足医疗需求的适应症，主要面向美国及全球生物制药市场运营。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
ARVN vs RBB — 直观对比
营收规模更大
ARVN
是对方的1.3倍
$32.3M
营收增速更快
RBB
高出71.7%
-59.1%
净利率更高
RBB
高出115.3%
-83.8%
自由现金流更多
RBB
多$101.8M
$-59.2M
两年增速更快
ARVN
近两年复合增速
7.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.9M | $32.3M |
| 净利润 | $-35.1M | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | -104.5% | 39.5% |
| 净利率 | -83.8% | 31.5% |
| 营收同比 | -59.1% | 12.6% |
| 净利润同比 | 28.7% | 132.1% |
| 每股收益（稀释后） | $-0.48 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARVNRBB
| Q4 25 | — | $32.3M | ||
| Q3 25 | $41.9M | $32.6M | ||
| Q2 25 | — | $35.8M | ||
| Q1 25 | $188.8M | $28.5M | ||
| Q4 24 | $59.2M | $28.7M | ||
| Q3 24 | $102.4M | $30.3M | ||
| Q2 24 | $76.5M | $27.5M | ||
| Q1 24 | $25.3M | $28.2M |
净利润ARVNRBB
| Q4 25 | — | $10.2M | ||
| Q3 25 | $-35.1M | $10.1M | ||
| Q2 25 | — | $9.3M | ||
| Q1 25 | $82.9M | $2.3M | ||
| Q4 24 | $-45.1M | $4.4M | ||
| Q3 24 | $-49.2M | $7.0M | ||
| Q2 24 | $-35.2M | $7.2M | ||
| Q1 24 | $-69.4M | $8.0M |
营业利润率ARVNRBB
| Q4 25 | — | 39.5% | ||
| Q3 25 | -104.5% | 40.7% | ||
| Q2 25 | — | 36.1% | ||
| Q1 25 | 37.8% | 11.2% | ||
| Q4 24 | -98.1% | 17.6% | ||
| Q3 24 | -58.9% | 31.6% | ||
| Q2 24 | -63.4% | 35.6% | ||
| Q1 24 | -329.2% | 39.9% |
净利率ARVNRBB
| Q4 25 | — | 31.5% | ||
| Q3 25 | -83.8% | 31.2% | ||
| Q2 25 | — | 26.1% | ||
| Q1 25 | 43.9% | 8.0% | ||
| Q4 24 | -76.2% | 15.3% | ||
| Q3 24 | -48.0% | 23.1% | ||
| Q2 24 | -46.0% | 26.4% | ||
| Q1 24 | -274.3% | 28.4% |
每股收益（稀释后）ARVNRBB
| Q4 25 | — | $0.59 | ||
| Q3 25 | $-0.48 | $0.59 | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | $1.14 | $0.13 | ||
| Q4 24 | $-0.63 | $0.26 | ||
| Q3 24 | $-0.68 | $0.39 | ||
| Q2 24 | $-0.49 | $0.39 | ||
| Q1 24 | $-0.97 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $787.6M | $212.3M |
| 总债务越低越好 | $600.0K | $119.9M |
| 股东权益账面价值 | $564.4M | $523.4M |
| 总资产 | $844.3M | $4.2B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资ARVNRBB
| Q4 25 | — | $212.3M | ||
| Q3 25 | $787.6M | $234.9M | ||
| Q2 25 | — | $191.9M | ||
| Q1 25 | $954.3M | $238.8M | ||
| Q4 24 | $1.0B | $257.7M | ||
| Q3 24 | $1.1B | $349.4M | ||
| Q2 24 | $1.2B | $252.8M | ||
| Q1 24 | $1.2B | — |
总债务ARVNRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | $600.0K | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | $700.0K | $119.6M | ||
| Q4 24 | $800.0K | $119.5M | ||
| Q3 24 | $800.0K | $119.4M | ||
| Q2 24 | $900.0K | $119.3M | ||
| Q1 24 | $900.0K | $119.2M |
股东权益ARVNRBB
| Q4 25 | — | $523.4M | ||
| Q3 25 | $564.4M | $514.3M | ||
| Q2 25 | — | $517.7M | ||
| Q1 25 | $660.1M | $510.3M | ||
| Q4 24 | $561.7M | $507.9M | ||
| Q3 24 | $586.0M | $509.7M | ||
| Q2 24 | $600.2M | $511.3M | ||
| Q1 24 | $609.7M | $514.0M |
总资产ARVNRBB
| Q4 25 | — | $4.2B | ||
| Q3 25 | $844.3M | $4.2B | ||
| Q2 25 | — | $4.1B | ||
| Q1 25 | $1.0B | $4.0B | ||
| Q4 24 | $1.1B | $4.0B | ||
| Q3 24 | $1.2B | $4.0B | ||
| Q2 24 | $1.3B | $3.9B | ||
| Q1 24 | $1.2B | $3.9B |
负债/权益比ARVNRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | 0.00× | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | 0.00× | 0.23× | ||
| Q4 24 | 0.00× | 0.24× | ||
| Q3 24 | 0.00× | 0.23× | ||
| Q2 24 | 0.00× | 0.23× | ||
| Q1 24 | 0.00× | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.1M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-59.2M | $42.6M |
| 自由现金流率自由现金流/营收 | -141.3% | 131.8% |
| 资本支出强度资本支出/营收 | 0.2% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-361.6M | $73.5M |
8季度趋势，按日历期对齐
经营现金流ARVNRBB
| Q4 25 | — | $43.4M | ||
| Q3 25 | $-59.1M | $2.1M | ||
| Q2 25 | — | $21.7M | ||
| Q1 25 | $-88.9M | $7.8M | ||
| Q4 24 | $-84.1M | $58.5M | ||
| Q3 24 | $-128.0M | $24.5M | ||
| Q2 24 | $50.3M | $11.7M | ||
| Q1 24 | $-97.5M | $4.8M |
自由现金流ARVNRBB
| Q4 25 | — | $42.6M | ||
| Q3 25 | $-59.2M | $1.8M | ||
| Q2 25 | — | $21.6M | ||
| Q1 25 | $-89.3M | $7.6M | ||
| Q4 24 | $-84.4M | $57.7M | ||
| Q3 24 | $-128.7M | $24.2M | ||
| Q2 24 | $49.6M | $11.5M | ||
| Q1 24 | $-97.6M | $4.7M |
自由现金流率ARVNRBB
| Q4 25 | — | 131.8% | ||
| Q3 25 | -141.3% | 5.4% | ||
| Q2 25 | — | 60.2% | ||
| Q1 25 | -47.3% | 26.7% | ||
| Q4 24 | -142.6% | 201.0% | ||
| Q3 24 | -125.7% | 80.0% | ||
| Q2 24 | 64.8% | 42.0% | ||
| Q1 24 | -385.8% | 16.6% |
资本支出强度ARVNRBB
| Q4 25 | — | 2.5% | ||
| Q3 25 | 0.2% | 1.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | 0.2% | 0.6% | ||
| Q4 24 | 0.5% | 2.7% | ||
| Q3 24 | 0.7% | 0.8% | ||
| Q2 24 | 0.9% | 0.5% | ||
| Q1 24 | 0.4% | 0.5% |
现金转化率ARVNRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | -1.07× | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
